Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling

References

• AKHTAR, M. and WRIGHT, J. N., 1991, A unified mechanistic view of oxidative reactions by P-450 and related Fe -containing enzymes. Natural Product Reports, 8, 527–551.
   PubMed Web of Science ®Google Scholar
• ALLEN, J. G., EAST, P. B., FRANCIS, R. J. and HAIGH, J. L., 1975, Metabolism of debrisoquine sulphate. Identification of some urinary metabolites in rat and man. Drug Metabolism and Disposition, 3, 332–337.
   PubMed Web of Science ®Google Scholar
• ANGELO, M., DRING, L. G., IDLE, J. R., LANCASTER, R., MAHGOUB, A. and Sly, R. L., 1978, Defective alicyclic hydroxylation of debrisoquine in man. British Journal of Clinical Pharmacology, 4, 725P.
   Google Scholar
• BERTILSSON, L., MEESE, C. O., YUE, Q. Y., DAHL, M. L., INGELMAN -SUNDBERG, M., JOHANSSON, I., S;kwE, J. and EICHELBAUM, M., 1993, Quinidine inhibition of debrisoquine S( + )-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypes. Pharmacogenetics, 3, 94–100.
   Google Scholar
• CHE, H., DE GROOT, M. J., VERMEULEN, N. P. E. and HANSLIK, R. P., 1997, Oxidative N-dealltylation of p-cyclopropyl-N, N-dimethylanaline. A substituent effect on a radical clock reaction rationalized by ab initio calculations on radical cation intermediates. Journal of Organic Chemistry, 62, 8227–8230.
   Google Scholar
• CLEMENT, B., SHULTZE -MOSGAU, M.-H. and WOHLERS, H., 1993, Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Biochemical Phar-macology, 46, 2249–2267.
   Google Scholar
• CRFSPI, C. L., STEIMEL, D. T., PENMAN, B. W., KORZEKWA, K. R., FERNANDEZ -SALGUERO, P., BUTERS J. T. M., GELBOIN, H. V., GONZALEZ, F. J., IDLE, J. R. and DALY, A. K., 1995, Comparison of substrate metabolism by wild-type CYP2D6 protein and a variant containing methionine, not valine, at position 374. Pharmacogenetics, 5, 234–243.
   Google Scholar
• DE GROOT, M. J., ACKLAND, M. J., HORNE, V. A., Awc, A. A. and JONES, B. C., 1999, Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. Journal of Medicinal Chemistry, 42, 1515–1524.
   PubMed Web of Science ®Google Scholar
• DE GROOT, M. J., BIJLOO, G. J., MARTENS, B. J., VAN ACKER, F. A. A. and VERMEULEN, N. P. E., 1997, A refined substrate model for human cytochrome P450 2D6. Chemical Research in Toxicology, 10, 41–48.
   Google Scholar
• DE GROOT, M. J., DONNE -OP DEN KELDER, G. M., COMMANDEUR, J. N. M., VAN LENTHE, J. H. and VERMEULEN, N. P. E., 1995, Metabolite predictions for para-substituted anisoles based on ab initio complete active space self consistent field calculations. Chemical Research in Toxicology, 8, 437–443.
   Google Scholar
• DE GROOT, M. J., VERMEULEN, N. P. E., KRAMER, J. D., VAN ACKER, F. A. A. and DONNE -OP DEN KELDER, G. M., 1996, Three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. Chemical Research in Toxicolology, 9, 1079–1091.
   Google Scholar
• EIREMAN, B., EDLUND, P. O., TJERNBERG, A., DALEN, P., DAHL M.-L. and BERTILSSON, L., 1998, 1-and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans. Drug Metabolism and Disposition, 26, 1096–1101.
   Google Scholar
• ELLIS, S. W., CHING, M. S., WATSON, P. F., HENDERSON, C. J., SIMULA, A. P., LENNARD, M. S., TUCKER, G. T. and WOODS, H. F., 1992, Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast. Biochemical Pharmacology, 44, 617–620.
   PubMed Web of Science ®Google Scholar
• ELLIS, S. W., HAYHURST, G. P., SMITH, G., LIGHTFOOT, T., WONG, M. M. S., SIMULA, A. P., ACKLAND, M. J., STERNBERG, M. J. E., LENNARD, M. S., TUCKER, G. T. and WOLF, C. R., 1995, Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. Journal of Biological Chemistry, 270, 29055–29058.
   Google Scholar
• ELLIS, S. W., ROWLAND, K., ACKLAND, M. J., REKKA, E., SIMULA, A. T., LENNARD, M. S., WOLF, C. R. and TUCKER, G. T., 1996, Influence of amino acid residue 374 of cytochrome P450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochemical Journal, 361, 647–654.
   Web of Science ®Google Scholar
• IDLE, J. R., MAHGOUB, A., ANGELO, M. M., DIUNG, L. G., LANCASTER, R. and SMITH, R. L., 1979, The metabolism of [14C] -debrisoquine in man. British Journal of Clinical Pharmacology, 7, 257–266.
   PubMed Web of Science ®Google Scholar
• KORZEKWA, K. R., TRAGER, W. F., GOUTERMAN M., SPRANGLER, D. and LOWE, G. H., 1985, Cytochrome P450 mediated aromatic oxidations: a theoretical study. Journal of American Chemical Society, 107, 4273–4279.
   Google Scholar
• KRONBACH, T., MATHYS, D., GUT, J., CALINT, T. and MEYER, U. A., 1987, High-performance liquid chromatographic assays for bufuralol 1 '-hydroxylase, debrisoquine 4-hydroxylase and dextro-methorphan 0-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Analytical Biochemistry, 164, 24–32.
   Web of Science ®Google Scholar
• KOYMANS, L. M. H., VAN LENTHE, J. H., VAN DE STRAAT, R., DONNE -OP DEN KELDER, G. M. and VERMEULEN, N. P. E., 1989, A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. Chemical Research in Toxicology, 2, 60–66.
   Google Scholar
• KOYMANS, L. M. H., VERMEULEN, N. P. E., BRAARSLAG, A. and Do NNE -OP DEN KELDER, G. M., 1993, A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building. Journal of Computer-Aided Molecular Design, 7, 281–289.
   Google Scholar
• KRYNETSKI, E. Y., DamsA, V. L., KOVALERA, I. E. and Luzikev, V. N., 1995, High yield expression of functionally active human liver CYP2D6 in yeast cells. Pharmacogenetics, 5, 103–109.
   PubMedGoogle Scholar
• LEWIS, D. F. V., EDDERSHAW, P. J., GOLDFARB, P. S. and TARBIT, M. H., 1997, Molecular modelling of cytochrome P4502d6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism. Xenobiotica, 27, 319–340.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MAHGOUB, A., IDLE, J. R., DRING, L. G., LANCASTER, R. and SMITH, R. L., 1977, Polymorphic hydroxylation of debrisoquine in man. Lancet, i, 584–586.
   Google Scholar
• MODI, S., PAIN, M. J., SUTCLIFFE, M. J., LIAN, L.-Y., PRIMROSE, W. U., WOLF, C. R. and ROBERTS, G. C. K., 1996, A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry, 35, 4540–4550.
   Google Scholar
• MUELLER, E. J., LoiDA, P. J. and SLIGAR, G. S., 1996, Twenty-five years of P450cam research: mechanistic insights into catalysis. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 — Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 83–124.
   Google Scholar
• OMURA, T. and SATO, R., 1964, Carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• ORTIZ DE MONTELLANO, P. R., 1996, Oxygen activation and reactivity. In P. R. Ortiz de Montellano (ed.), Cytochrome P450 — Structure, Mechanism, and Biochemistry, 2nd edn (New York: Plenum), pp. 245–304.
   Google Scholar
• OTTON, S. V., CREWE, H. K., LENNARD, M. S., TUCKER, G. T. and WOODS, H. F., 1998, Use of quinidine inhibition to define the role of sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 247, 242–247.
   Google Scholar
• PENMAN, B. W., REECE, J., SMITH, T., YANG, C. S., GELBOIN, H. V., GONZALEZ, F. J. and CRESPI, C. L., 1993, Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. Pharmacogenetics, 3, 28–39.
   PubMedGoogle Scholar
• RILEY, P. and HANZLIK, R. P., 1994, Electron transfer in P450 mechanisms. Microsomal metabolism of cyclopropylbenzene and p-cyclopropylanisole. Xenobiotica, 24, 1–16.
   PubMed Web of Science ®Google Scholar
• RITCHIE, J. C., CROTHERS, M. J., SHAH, R. R., IDLE, J. R. and Smrm, R. L., 1986, The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis. Xenobiotica, 16, 503–509.
   PubMed Web of Science ®Google Scholar
• Rizx, P. N. and HANZLIK, R. P., 1995, Oxidative and non-oxidative metabolism of 4-iodoanisole by rat liver microsomes. Xenobiotica, 25, 143–150.
   PubMed Web of Science ®Google Scholar
• SILAS, J. H., LENNARD, M. S., TUCKER, G. T., SMITH, A. J., MALCOLM, S. L. and MARTEN, T. R., 1978, The disposition of debrisoquine in hypertensive patients. British Journal of Clinical Pharmacology, 5, 27–34.
   PubMed Web of Science ®Google Scholar
• TER LAAK, A. M., 1995, Histamine Hi-receptor agonists and antagonists. Molecular modeling and drug design. PhD thesis, Vrije Universiteit Amsterdam.
   Google Scholar
• TUCKER, G. T., SILAS, J. H., LYUN, A., LENNARD, M. S. and SMITH, A. J., 1977, Polymorphic hydroxylation of debrisoquine. Lancet, ii, 718.
   Google Scholar
• WILLIAMS, M. L., LENNARD, M. S., MARTIN, I. J. and TUCKER, G. T., 1994, Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cyto-chromes P450. Carcinogenesis, 15, 2733–2738.
   PubMed Web of Science ®Google Scholar
• WOOLHOUSE, N. M., ANDOH, B., MAHGOUB, A., SLOAN, T. P., IDLE, J. R. and SMITH, R. L., 1997, Debrisoquine hydroxylation polymorphism among Ghanaians and Caucasians. Clinical Phar-macology and Therapeutics, 26, 584–591.
   Google Scholar
• ZAKHARIVA 0., GRODZICKI, M., TRAUTWEIN, A. X., VEEGER, C. and RIETJENS, I. M. C. M., 1998, Molecular orbital study of porphyrin—substrate interactions in cytochrome P450 catalysed aromatic hydroxylation of substituted anilines. Biophysical Chemistry, 73, 9–203.
   Google Scholar